seed
Stage
About
Helex is a biotechnology company developing genomic medicines using proprietary lipid nanoparticle delivery and gene editing technologies to create targeted non-viral therapies for genetic kidney diseases including Autosomal Dominant Polycystic Kidney Disease.
Explore Helex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.